Fecal Microbiota Transplantation & Colorectal cancer

The role of microbiota in the development of colorectal cancer.


Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer.


Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures.


Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.


Microbiota and gastrointestinal cancer.


Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.


Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.


[Gut microbiota: What impact on colorectal carcinogenesis and treatment?].


Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.


[Role of gut microbiota in carcinogenesis and treatment for colorectal cancer].


Potential of fecal microbiota for early-stage detection of colorectal cancer.


Faecal microbiota transplantation, a promising way to treat colorectal cancer.


Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apc(min/+) mice.


The Human Gut Microbiome - A Potential Controller of Wellness and Disease.


Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?


[The Relationship between Gut Microbiome, Immune System, and Cancer].


Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation.


YYFZBJS ameliorates colorectal cancer progression in Apc(Min/+) mice by remodeling gut microbiota and inhibiting regulatory T-cell generation.


The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.


Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.


Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0.


Epithelial calcineurin controls microbiota-dependent intestinal tumor development.


Predictive values of colon microbiota in the treatment response to colorectal cancer.


Fucosylation Deficiency in Mice Leads to Colitis and Adenocarcinoma.


Impact of microbiota in colorectal carcinogenesis: lessons from experimental models.


Neohesperidin prevents colorectal tumorigenesis by altering the gut microbiota.


Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.


Inhibition effect of glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition.


Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions.


Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile.


NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.


Concomitant decrease of double-positive lymphocyte population CD4CD8alphaalpha and Faecalibacterium prausnitzii in patients with colorectal cancer.